CD4 and neoplasm: We also isolated two MHC class II-restricted TCRs from two other vaccinated patients in this study ([32] and Inderberg, Wälchli et al., unpublished data) which shifted the focus of our development platform to CD4 T-cell derived TCRs due to the central role of CD4 T cells in anti-tumour immune responses.